Amgen Recalls Kyprolis Vials Due to Potential Glass Cracks
Amgen is recalling 11,434 vials of Kyprolis (carfilzomib) injection because potential cracks in the glass vials may compromise sterility.
- Product
- KYPROLIS — KYPROLIS (CARFILZOMIB)
- Category
- Drug
- Distribution
- 1 state